Upon histological re-review according to WHO 2016 guidelines by the HERBY Pathology Committee, BRAF_V600E, cases were all found to comprise the epithelioid variant of grade IV GBM, while the NF1 cases were all classified as the giant cell variant (Figure 6B). The gene discussed is NF1; the disease is glioblastoma.